Brind.

Rezolute, Inc. appointed Sunil Karnawat as Chief Commercial Officer, following his previous roles at Cytokinetics, Novo Nordisk, and Johnson & Johnson.

1 report, 1 independent Updated Aug 20

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Cytokinetics Novo Nordisk

Keep exploring

The entities involved

Cytokinetics
company in South San Francisco, United States
- Price targets for UDR were adjusted by Cantor Fitzgerald, Scotiabank, and Royal Bank of Canada on May 26, 2026.Sun 00:44
Novo Nordisk
Danish pharmaceutical company
- BridgeBio and Novo Nordisk have both made filings under the KXCO Ontology.Mon 10:09
- CMS introduced the Medicare drug price negotiation program, and companies are facing challenges regarding pricing and market access.Mon 00:08

Coverage

Newest first; wire copies grouped

Aug 20GlobeNewswireRezolute Appoints Seasoned Commercial Executive Sunil Karnawat as Chief Commercial Officer Experienced commercial and biopharmaceuticals leader to spearhead launch strategy and global market readines